Archives: Partners

The National Collaborating Centre for Indigenous Health (NCCIH) is making significant strides in support of a renewed public health system that is inclusive and respectful of diverse First Nations, Inuit and Métis peoples. NCCIH’s collaborations in knowledge sharing extend beyond traditional boundaries — institutional, jurisdictional, geographical and professional — to address the multi-faceted and structural issues underpinning Indigenous health. These collaborations continue to strengthen the links between evidence, knowledge, practice and policy in support of the public health goals of First Nations, Inuit and Métis peoples.

Established in 2005 by the Government of Canada, and funded through the Public Health Agency of Canada, the NCCIH is one of six centres in the National Collaborating Centres for Public Health program, each focusing on a different aspect of public health. Together, the centres help improve response to chronic disease and injury, infectious diseases, environmental health and health disparities.

Visit NCCIH’s website for more information.

The major objective of the Lotte & John Hecht Memorial Foundation is the investigation and support of novel, innovative and disruptive approaches, particularly in the treatment of cancer.

Kids Brain Health Network is the new name of NeuroDevNet, the first trans-Canada initiative to focus on improving diagnosis, treatment and support for families raising children with brain-based disabilities.

Kids Brain Health provides innovative training opportunities to seed a new generation of Canadian researchers dedicated to the same objectives, and empowers communities with tools and information to promote earlier diagnosis, better treatment and optimal outcomes for children today, and in the future.

Kids Brain Health’s current research projects focus on autism spectrum disorder, cerebral palsy, fetal alcohol spectrum disorder, sleep, the social determinants of health and health economics, as supported by collaboration with core services in neuroethics, neuroinformatics and knowledge translation.

Since 1978, the Kelowna General Hospital (KGH) Foundation has worked with a generous community to raise funds to support world-class health care, research and innovation close to home for a rapidly expanding and diverse population in the Interior of BC. Today, the KGH Foundation is the lead fundraising organization for Kelowna General Hospital, JoeAnna’s House, Hospice House, Brookhaven and Cottonwoods. For more information, visit kghfoundation.com.

The Interior Health Authority (IH) was created in 2001 to deliver health-care services to the population of the southern interior of British Columbia, now numbering over 725,000. The geographic area for which IH has responsibility covers almost 215-thousand square kilometres and includes several larger cities such as Kelowna, Kamloops, Cranbrook and Vernon and, most notably, a host of rural and remote communities. IH employs 18,500 people, including 6,500 professional clinicians and 1,500 physicians.

For more information, please refer to this website. IH has had roles in education, training and research since its inception in 2001. IH has over 240 active studies currently including a broad range of topics. For specific information about research in IH, click here.

Crohn’s and Colitis Canada (CCC) was founded in 1974 by a group of parents whose children were diagnosed with inflammatory bowel disease (IBD). They were concerned about the lack of funding for IBD research and they were interested in learning more about Crohn’s disease and ulcerative colitis.

From that small but dedicated group, CCC has grown to become a world leader in IBD research funding. Crohn’s and Colitis Canada is the country’s largest non-governmental funder of Crohn’s and colitis research and is the single largest patient organization in Canada focused on Crohn’s disease and ulcerative colitis, with over 40 volunteer chapters across the country.

Through the support of its generous sponsors and donors, CCC funds research projects that probe the mysteries of IBD. Life-altering treatments have been developed as a result of these discoveries, and, one day, a cure will be found.

Cassie & Friends Society is on a mission to make life better for kids and families affected by Juvenile Arthritis and other rheumatic diseases.

Juvenile Arthritis (JA) is a debilitating, autoimmune disease that affects 3 in 1,000 children in Canada. JA attacks the joints, causing pain, fatigue and mobility challenges, but it can also attack vital organs, including the eyes, making it a very serious condition in children.

Since 2007, Cassie & Friends Society has raised over $1,000,000 to fund research, pediatric rheumatology programs, equipment, support services and educational events to ensure kids and families with rheumatic diseases are not alone. That’s because, despite being one of the most common chronic childhood health issues in Canada, JA still remains relatively unknown and highly under-resourced.

As parents, the founders of the Society have felt firsthand the isolation, pain, lack of community awareness and critical gaps in support surrounding JA and other rheumatic diseases kids face. The Society’s priority is to be there for kids and families from the initial fear and disbelief of diagnosis through the endless hospital visits, needles, medications, scans and terrifying unknowns. That’s why Cassie & Friends Society exists: it’s a charity that’s focussed just on kids and their lives with Juvenile Arthritis and other rheumatic diseases.

Inspired by one family’s search for a cure, the Breast Cancer Society of Canada’s mission is to engage in grassroots fundraising that supports patient focused research for diagnosis, treatment and prevention.

The Breast Cancer Society of Canada continues to embrace the grassroots philosophy through a strong belief in a one-on-one approach with donors, event organizers and business partners. With the help of many dedicated volunteers across Canada, the organization is able to “support its supporters.”

The Breast Cancer Society of Canada truly believes that every dollar raised brings us one step closer to a cure.

BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer.

BioCanRx does this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life.

Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.